scholarly article | Q13442814 |
P2093 | author name string | D Bagchi | |
L Zhan | |||
G Maulik | |||
N Maulik | |||
V P Menon | |||
M Thirunavukkarasu | |||
S Varma Penumathsa | |||
P2860 | cites work | Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes | Q22008015 |
Signal transduction of eNOS activation | Q28145425 | ||
Regulated transport of the glucose transporter GLUT4 | Q28216848 | ||
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 | ||
Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function | Q28379541 | ||
Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells | Q28506688 | ||
Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4 | Q28580853 | ||
Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells | Q28586458 | ||
Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo | Q28609900 | ||
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha | Q28616168 | ||
The caveolae membrane system | Q29614726 | ||
Caveolins, liquid-ordered domains, and signal transduction | Q33752828 | ||
5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle | Q33869428 | ||
Cardioprotective effect of resveratrol, a natural antioxidant derived from grapes. | Q34510449 | ||
Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis | Q35168497 | ||
Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat | Q35762325 | ||
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase | Q36980730 | ||
Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. | Q40590121 | ||
Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action | Q41081651 | ||
Caveolae and caveolins | Q41099734 | ||
Insulin-stimulated glucose uptake involves the transition of glucose transporters to a caveolae-rich fraction within the plasma membrane: implications for type II diabetes | Q41809606 | ||
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy | Q42455926 | ||
Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. | Q42476103 | ||
Localization of the insulin receptor in caveolae of adipocyte plasma membrane | Q42809364 | ||
Functional consequence of targeting protein kinase B/Akt to GLUT4 vesicles | Q42813477 | ||
Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase | Q43678591 | ||
Pharmacological preconditioning with resveratrol: role of nitric oxide | Q43988537 | ||
Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects | Q44081019 | ||
Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells | Q44468960 | ||
Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle | Q44987298 | ||
Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent | Q46191643 | ||
Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats. | Q50703047 | ||
Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting. | Q51620236 | ||
Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus. | Q54348903 | ||
Caveolin-1 regulates shear stress-dependent activation of extracellular signal-regulated kinase | Q73630661 | ||
AMP-activated protein kinase phosphorylation of endothelial NO synthase | Q74456171 | ||
Compartmentalization of phosphatidylinositol 4,5-bisphosphate in low-density membrane domains in the absence of caveolin | Q74550725 | ||
Relaxant effect of trans-resveratrol on isolated porcine coronary arteries | Q77372342 | ||
Resveratrol, a natural product derived from grape, exhibits antiestrogenic activity and inhibits the growth of human breast cancer cells | Q77402133 | ||
Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase | Q77410226 | ||
P433 | issue | 6A | |
P921 | main subject | membrane raft | Q424178 |
P304 | page(s) | 2350-2361 | |
P577 | publication date | 2008-12-01 | |
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. | |
P478 | volume | 12 |
Q21092211 | A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice |
Q37978852 | A review on chemical and biological properties of Cayratia trifolia Linn. (Vitaceae). |
Q38944416 | Akt2 knockout mitigates chronic iNOS inhibition-induced cardiomyocyte atrophy and contractile dysfunction despite persistent insulin resistance |
Q26747497 | Angiogenesis in Ischemic Stroke and Angiogenic Effects of Chinese Herbal Medicine |
Q92150828 | Anti-Diabetic Effect of a Shihunine-Rich Extract of Dendrobium loddigesii on 3T3-L1 Cells and db/db Mice by Up-Regulating AMPK-GLUT4-PPARα |
Q37512665 | Antidiabetic Effects of Resveratrol: The Way Forward in Its Clinical Utility. |
Q37653755 | Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice |
Q55021760 | Biological Activities of Stilbenoids. |
Q36185263 | Cadmium toxicity induces ER stress and apoptosis via impairing energy homoeostasis in cardiomyocytes |
Q35204828 | Cardiac NO signalling in the metabolic syndrome |
Q33933399 | Cardiac energy metabolism and oxidative stress biomarkers in diabetic rat treated with resveratrol. |
Q35251097 | Cardiac insulin resistance and microRNA modulators |
Q33718319 | Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway |
Q91646684 | Caveolin as a Novel Potential Therapeutic Target in Cardiac and Vascular Diseases: A Mini Review |
Q35286413 | Caveolins in cardioprotection - translatability and mechanisms |
Q28252560 | Cellular and molecular effects of resveratrol in health and disease |
Q29347101 | Chronic ethanol feeding impairs AMPK and MEF2 expression and is associated with GLUT4 decrease in rat myocardium. |
Q27012844 | Diabetic complications in pregnancy: is resveratrol a solution? |
Q90055421 | Effect of resveratrol on SNARE proteins expression and insulin resistance in skeletal muscle of diabetic rats |
Q34389805 | Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests |
Q64230377 | Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease |
Q38663414 | Effects of resveratrol on eNOS in the endothelium and the perivascular adipose tissue |
Q36261141 | GDM-Induced Macrosomia Is Reversed by Cav-1 via AMPK-Mediated Fatty Acid Transport and GLUT1-Mediated Glucose Transport in Placenta |
Q34008856 | High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells |
Q42730932 | High dose of dietary resveratrol enhances insulin sensitivity in healthy rats but does not lead to metabolite concentrations effective for SIRT1 expression |
Q37015027 | Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling. |
Q37914071 | Mechanism of action of natural products used in the treatment of diabetes mellitus. |
Q38248057 | Mediterranean Way of Drinking and Longevity |
Q28554383 | Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway |
Q38039247 | Molecular mechanisms of the cardiovascular protective effects of polyphenols. |
Q46034115 | Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection. |
Q41910943 | New approach to modulate retinal cellular toxic effects of high glucose using marine epa and dha |
Q33957346 | Possible involvement of caveolin in attenuation of cardioprotective effect of ischemic preconditioning in diabetic rat heart |
Q38460480 | Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies |
Q53687735 | Potential Hypoglycaemic and Antiobesity Effects of Senna italica Leaf Acetone Extract. |
Q39645414 | Prenylated chalcones 4‐hydroxyderricin and xanthoangelol stimulate glucose uptake in skeletal muscle cells by inducing GLUT4 translocation |
Q36830372 | Regulation of hepatic glucose uptake and storage in vivo |
Q42705723 | Regulatory effects of resveratrol on glucose metabolism and T-lymphocyte subsets in the development of high-fat diet-induced obesity in C57BL/6 mice |
Q35445765 | Resveratrol ameliorates high glucose and high-fat/sucrose diet-induced vascular hyperpermeability involving Cav-1/eNOS regulation |
Q91641055 | Resveratrol and Diabetic Cardiomyopathy: Focusing on the Protective Signaling Mechanisms |
Q64112604 | Resveratrol and Its Effects on the Vascular System |
Q91741422 | Resveratrol and Vascular Function |
Q38212906 | Resveratrol and diabetes |
Q37995917 | Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies |
Q38258814 | Resveratrol and endothelial nitric oxide. |
Q37060275 | Resveratrol attenuates lipopolysaccharide-induced dysfunction of blood-brain barrier in endothelial cells via AMPK activation |
Q94017881 | Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium |
Q35022230 | Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. |
Q35147432 | Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase |
Q36099455 | Resveratrol: French paradox revisited |
Q37445518 | Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease |
Q42650350 | Resveratrol: a supplementation for men or for mice? |
Q54841829 | Role of red grape polyphenols as antidiabetic agents. |
Q39432694 | Role of resveratrol in the management of insulin resistance and related conditions: Mechanism of action |
Q46946033 | Roles and Mechanisms of Herbal Medicine for Diabetic Cardiomyopathy: Current Status and Perspective |
Q38903618 | Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts. |
Q38918022 | Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol |
Q36281133 | Sirtuin biology and relevance to diabetes treatment |
Q35315250 | Suppression of eNOS-derived superoxide by caveolin-1: a biopterin-dependent mechanism |
Q26999376 | Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol |
Q28073279 | Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular Diseases |
Q33872257 | The MARCH family E3 ubiquitin ligase K5 alters monocyte metabolism and proliferation through receptor tyrosine kinase modulation |
Q46480984 | The antioxidant effect of mulberry and jamun fruit wines by ameliorating oxidative stress in streptozotocin-induced diabetic Wistar rats |
Q53659625 | The effects of resveratrol on flap survival in diabetic rats. |
Q37391764 | UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK. |
Q35421401 | Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis |
Q36571926 | α-Lipoic acid attenuates cardiac fibrosis in Otsuka Long-Evans Tokushima Fatty rats |
Search more.